Trexquant Investment LP Alkermes Plc. Transaction History

Trexquant Investment LP

$8.06 Billion
Q4 2024

A detailed history of Trexquant Investment LP transactions in Alkermes Plc. stock. As of the latest transaction made, Trexquant Investment LP holds 104,467 shares of ALKS stock, worth $3.56 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

104,467

Previous 356,541 70.7%

Holding current value

$3.56 Million

Previous $9.98 Million 69.9%

% of portfolio

0.04%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$25.7 - $31.46 $6.48 Million - $7.93 Million	-252,074 Reduced 70.7%	104,467 $3 Million
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $5.06 Million - $6.27 Million	219,747 Added 160.64%	356,541 $9.98 Million
Q2 2024 Aug 13, 2024	BUY	$23.21 - $27.24 $1.45 Million - $1.7 Million	62,406 Added 83.89%	136,794 $3.3 Million
Q1 2024 May 14, 2024	BUY	$26.4 - $32.56 $1.96 Million - $2.42 Million	74,388 New	74,388 $2.01 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $953,205 - $1.12 Million	35,083 Added 22.51%	190,941 $5.35 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $2.42 Million - $2.87 Million	85,228 Added 120.67%	155,858 $4.88 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $1.36 Million - $1.56 Million	53,828 Added 320.37%	70,630 $1.99 Million
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $221,418 - $264,814	-10,092 Reduced 37.53%	16,802 $439,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $272,206 - $394,327	12,373 Added 85.21%	26,894 $601,000
Q2 2022 Aug 11, 2022	BUY	$26.4 - $30.54 $99,554 - $115,166	3,771 Added 35.08%	14,521 $433,000
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $248,002 - $300,892	10,750 New	10,750 $283,000
Q2 2021 Aug 12, 2021	SELL	$18.78 - $25.15 $211,218 - $282,862	-11,247 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$18.21 - $23.2 $204,807 - $260,930	11,247 New	11,247 $210,000
Q4 2020 Feb 11, 2021	SELL	$15.39 - $22.1 $1.02 Million - $1.47 Million	-66,352 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$16.16 - $20.66 $668,280 - $854,373	41,354 Added 165.43%	66,352 $1.1 Million
Q2 2020 Aug 07, 2020	BUY	$13.31 - $19.41 $114,080 - $166,363	8,571 Added 52.18%	24,998 $485,000
Q1 2020 May 08, 2020	SELL	$13.06 - $21.24 $176,061 - $286,336	-13,481 Reduced 45.07%	16,427 $237,000
Q4 2019 Feb 12, 2020	BUY	$17.29 - $21.74 $517,109 - $650,199	29,908 New	29,908 $610,000
Q3 2019 Nov 08, 2019	SELL	$19.51 - $24.28 $1.01 Million - $1.25 Million	-51,611 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$21.47 - $37.33 $1.11 Million - $1.93 Million	51,611 New	51,611 $1.16 Million
Q4 2017 Feb 09, 2018	SELL	$47.69 - $55.39 $204,637 - $237,678	-4,291 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$49.16 - $54.45 $210,945 - $233,644	4,291	4,291 $218,000

Others Institutions Holding ALKS

# of Institutions

375

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.59B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Alkermes Plc. Transaction History